Expanding the cytokine receptor alphabet reprograms T cells into diverse states Summary This Nature paper describes an engineered, orthogonal IL-2/IL-2Rβ platform that swaps intracellular domains (ICDs) from a wide range…
Clone copy number diversity is linked to survival in lung cancer Summary This Nature paper introduces ALPACA, a computational method that infers allele- and clone-specific copy-number profiles from multi-sample bulk…
Sun-powered flyers could explore the mysterious mesosphere Summary Researchers have demonstrated a one-centimetre-wide, solar‑powered levitating device that needs no moving parts. The tiny flyer uses thermal transpiration — a gas…
Acidic oxygen reduction by single-atom Fe catalysts on curved supports Summary The authors report a new Fe/N–C electrocatalyst architecture made of two-dimensional carbon layers decorated with numerous nanoprotrusions that host…
Controversial quantum-computing paper gets hefty correction — but concerns linger Summary The journal Science has lifted an editorial expression of concern and published a 20-page correction to the supplementary material…
No more fake news: Google now lets you prioritise El Reg, others in search results Summary Google has begun rolling out a “preferred sources” feature in the US and India…
Tsunami forecasting about to get a lot faster thanks to El Capitan super Summary Researchers from Lawrence Livermore National Laboratory, the Oden Institute (University of Texas at Austin) and Scripps…
.NET 10 preview out now, likely to be near feature-complete Summary Microsoft has published Preview 7 of .NET 10 (runtime and frameworks). The release adds a new WebSocketStream API, simplifies…
Who made the demo list for Trump’s fast-track nuclear reactor scheme? Summary America’s Department of Energy (DoE) has selected ten companies to work under the Nuclear Reactor Pilot Programme to…
First Antidote For Carbon Monoxide Poisoning ‘Cleans’ Blood In Minutes Summary An engineered protein based on a bacterial carbon-monoxide sensor (RcoM) has been reworked into a therapeutic candidate called RcoM-HBD-CCC.…
